SARS-CoV-2 Omicron BA.5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern

SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses

(2022) Wanwisa Dejnirattisai et al.   CELL

Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts tropism and fusogenicity

(2022) Bo Meng et al.   NATURE

Omicron’s feeble attack on the lungs could make it less dangerous

(2022) Max Kozlov   NATURE

Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron

(2022) Huiping Shuai et al.   NATURE

SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo

(2022) Kenrie P. Y. Hui et al.   NATURE

Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant

(2022) Rigel Suzuki et al.   NATURE

SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters

(2022) Peter J. Halfmann et al.   NATURE

Platform for isolation and characterization of SARS-CoV-2 variants enables rapid characterization of Omicron in Australia

(2022) Anupriya Aggarwal et al.   Nature Microbiology

Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum

(2022) Aekkachai Tuekprakhon et al.   CELL

Augmented neutralisation resistance of emerging omicron subvariants BA.2.12.1, BA.4, and BA.5

(2022) Prerna Arora et al.   LANCET INFECTIOUS DISEASES

Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5

(2022) Qian Wang et al.   NATURE

BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection

(2022) Yunlong Cao et al.   NATURE

Emergence of SARS-CoV-2 Omicron lineages BA.4 and BA.5 in South Africa

(2022) Houriiyah Tegally et al.   NATURE MEDICINE

Efficacy of Antibodies and Antiviral Drugs against Omicron BA.2.12.1, BA.4, and BA.5 Subvariants

(2022) Emi Takashita et al.   NEW ENGLAND JOURNAL OF MEDICINE

Neutralization Escape by SARS-CoV-2 Omicron Subvariants BA.2.12.1, BA.4, and BA.5

(2022) Nicole P. Hachmann et al.   NEW ENGLAND JOURNAL OF MEDICINE

Omicron spike function and neutralizing activity elicited by a comprehensive panel of vaccines

(2022) John E. Bowen et al.   SCIENCE

In vitro activity of therapeutic antibodies against SARS-CoV-2 Omicron BA.1, BA.2 and BA.5

(2022) Franck Touret et al.   Scientific Reports

Cryo-EM structures of SARS-CoV-2 Omicron BA.2 spike

(2022) Victoria Stalls et al.   Cell Reports

WHO International Standard for anti-SARS-CoV-2 immunoglobulin

(2021) Paul A Kristiansen et al.   LANCET

A versatile reverse genetics platform for SARS-CoV-2 and other positive-strand RNA viruses

(2021) Alberto A. Amarilla et al.   Nature Communications

SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants

(2021) Fiona Tea et al.   PLOS MEDICINE

SARS‐CoV‐2 Alpha, Beta, and Delta variants display enhanced Spike‐mediated syncytia formation

(2021) Maaran Michael Rajah et al.   EMBO JOURNAL

Evolution of enhanced innate immune evasion by SARS-CoV-2

(2021) Lucy G. Thorne et al.   NATURE

Rapid assessment of SARS-CoV-2–evolved variants using virus-like particles

(2021) Abdullah M. Syed et al.   SCIENCE

SARS-CoV-2 Omicron variant shows less efficient replication and fusion activity when compared with Delta variant in TMPRSS2-expressed cells

(2021) Hanjun Zhao et al.   Emerging Microbes & Infections

Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody

(2020) Dora Pinto et al.   NATURE

Analytical validity of nanopore sequencing for rapid SARS-CoV-2 genome analysis

(2020) Rowena A. Bull et al.   Nature Communications

Lentiviral Vector Production Titer Is Not Limited in HEK293T by Induced Intracellular Innate Immunity

(2019) Carolina B. Ferreira et al.   Molecular Therapy-Methods & Clinical Development

Investigations of prion and virus safety of a new liquid IVIG product

(2008) M. Stucki et al.   BIOLOGICALS